Hutch News

Hutch News

Stories tagged 'bone marrow transplant'

Common genetic disorder linked to increased death rate from cancer drug

Researchers recommend ‘caution’ when using the chemotherapy busulfan in patients with Gilbert’s syndrome

Oct. 27, 2016 | By Susan Keown / Fred Hutch News Service

As many as one of every 10 people has Gilbert's syndrome, which is typically benign and has even been linked to long life. But new research suggests that busulfan, a bone marrow transplant drug, is extra risky in people with the condition.

View story >


Physician-scientist Dr. Bruce Clurman named executive vice president and deputy director of Fred Hutch

Clurman will focus on team science, interdisciplinary collaboration in pursuit of new cures, said President and Director Dr. Gary Gilliland

Oct. 18, 2016 | By Rachel Tompa / Fred Hutch News Service

In his 25th year as a physician and researcher working at Fred Hutchinson Cancer Research Center, Dr. Bruce Clurman is getting ready to step into his newest role — executive vice president and deputy director of the Hutch.

View story >


Which cells to choose?

New study explores whether stem cells from bone marrow or blood offer transplant patients better quality of life

Aug. 16, 2016 | By Susan Keown / Fred Hutch News Service

A new study of blood stem-cell transplant patients found no difference in survival between patients who received transplants derived from bone marrow versus those who received transplants derived from circulating blood stem-cells. However, the bone marrow transplant patients did experience fewer related symptoms and side effects.

View story >


Can Timothy Ray Brown’s HIV cure be repeated?

'Patient B' joined a Boston research study to find out: Gary Steinkohl’s story — and legacy

Aug. 2, 2016 | By Mary Engel / Fred Hutch News Service

For a few exuberant months, Gary Steinkohl thought he had become only the second person in the world cured of HIV after Timothy Ray Brown. Then his hopes were dashed.

View story >


When do we say cure?

A loaded word for cancer patients, but researchers view ‘cure’ through lens of statistics

July 8, 2016 | By Rachel Tompa / Fred Hutch News Service

An individual patient may not hear the word "cure" on their oncologist's lips, but that doesn't mean the word has no meaning to researchers. It's just that it's very difficult to apply it to an individual person.

View story >


Experts from leading cancer centers ask, ‘Where’s the outcry?’

Antiviral drug for post-transplant complications now costs more than the transplant

June 2, 2016 | By Mary Engel / Fred Hutch News Service

A life-saving antiviral drug used to treat a type of severe pneumonia in children and adults who have undergone bone marrow transplants can now cost more than the transplant itself after the drug’s sole distributor, Valeant Pharmaceuticals, increased the price by almost 400 percent.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.